Skip to content
AnalystLens

Marvell Technology 8-K Report, Change in Control (Sep 16, 2024)

Reports
Corporate Changes
Filing Date
Filed September 16, 2024
Period End
September 15, 2024
Security
MRVL
In the record · 2021–202610-K510-Q178-K90

MRVL filed 5 annual reports (10-K), 17 quarterly reports (10-Q) and 90 current reports (8-K) between 2021 and 2026.

  1. Leadership change8-K · Aug ’22Aug ’22
  2. Material agreement8-K · Sep ’23Sep ’23
  3. Material agreement8-K · Nov ’26Nov ’26

Summary

Summary of the 8-K filed September 16, 2024. Cited figures are marked; the original filing is the authoritative source.

Marvell Technology, Inc. (MRVL) filed a Form 8-K on September 16, 2024 to report a board change under Item 5.02.

Director Dr. Ford Tamer notified the company that he would resign from its Board of Directors effective September 15, 2024. The filing states that the resignation is not the result of any dispute or disagreement with the company or the board on matters relating to its operations, policies, or practices. The filing is administrative in nature.

It contains no financial results, guidance, acquisition or divestiture news, or changes to executive officers, and it does not disclose the reason for the departure beyond the no-disagreement statement. Because the filing does not name a successor or describe committee changes, investors should treat it as a routine governance event with limited direct valuation impact.

For investors, the relevant follow-up is whether the board will fill the vacancy and whether Dr. Tamer's departure affects board committee composition or independence requirements. Such details would typically appear in a subsequent filing, such as a proxy statement or a further 8-K, rather than in this notice.

Key Highlights

  1. Director Dr. Ford Tamer resigned from Marvell's Board of Directors, effective September 15, 2024.
  2. The resignation was not due to any dispute or disagreement with the company or the board regarding operations, policies, or practices.
  3. Filed under Item 5.02 (Departure of Directors or Certain Officers), a routine governance disclosure.
  4. The filing contains no financial results, guidance, or quantitative financial data.
  5. No successor director or replacement appointment is announced in this filing.
  6. The filing includes the standard Cover Page Interactive Data File (XBRL) exhibit, as required for 8-K submissions.
  7. Limited direct impact on valuation; the relevant follow-up is board vacancy filling and any committee reassignments.

Frequently Asked Questions

  1. Why did Ford Tamer resign from Marvell's Board?

    The 8-K does not state a specific reason. It only confirms that his resignation was not the result of any dispute or disagreement with the company or the board on matters relating to operations, policies, or practices.

  2. When did the resignation take effect?

    Dr. Tamer's resignation became effective as of September 15, 2024, one day before the 8-K was filed on September 16, 2024.

  3. Does this resignation affect Marvell's financial performance or outlook?

    The filing contains no financial information or guidance. A single board departure is not typically material to financial results, so the direct impact on the company's outlook appears limited.

  4. Will Marvell replace Dr. Tamer on the board?

    The filing does not announce a successor. Investors should watch for a subsequent 8-K or proxy statement describing any new director appointment or changes to board size and committee composition.